EETs relax airway smooth muscle via an EpDHF effect:: BKCa channel activation and hyperpolarization

被引:51
作者
Benoit, C [1 ]
Renaudon, B [1 ]
Salvail, D [1 ]
Rousseau, E [1 ]
机构
[1] Univ Sherbrooke, Fac Med, Dept Physiol & Biophys, Le Bilarium, Sherbrooke, PQ J1H 5N4, Canada
关键词
epoxyeicosatrienoic acids; bronchorelaxation; membrane potential; potassium conductance; eicosanoids; planar lipid bilayers; epithelium-derived hyperpolarizing factors; large-conductance calcium-activated potassium channel;
D O I
10.1152/ajplung.2001.280.5.L965
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Epoxyeicosatrienoic acids (EETs) are produced from arachidonic acid via the cytochrome P-450 epoxygenase pathway. EETs are able to modulate smooth muscle tone by increasing K+ conductance, hence generating hyperpolarization of the tissues. However, the molecular mechanisms by which EETs induce smooth muscle relaxation are not fully understood. In the present study, the effects of EETs on airway smooth muscle (ASM) were investigated using three electrophysiological techniques. 8,9-EET and 14,15-EET induced concentration-dependent relaxations of the ASM precontracted with a muscarinc agonist (carbamylcholine chloride), and these relaxations were partly inhibited by 10 nM iberiotoxin (IbTX), a specific large-conductance Ca2+-activated K+ (BKCa) channel blocker. Moreover, 3 muM 8,9- or 14,15- EET induced hyperpolarizations of -12 +/- 3.5 and -16 +/- 3 mV, with EC50 values of 0.13 and 0.14 mM, respectively, which were either reversed or blocked on addition of 10 nM IbTX. These results indicate that BKCa channels are involved in hyperpolarization and participate in the relaxation of ASM. In addition, complementary experiments demonstrated that 8,9- and 14,15-EET activate reconstituted BKCa channels at low free Ca2+ concentrations without affecting their unitary conductance. These increases in channel activity were IbTX sensitive and correlated well with the IbTX-sensitive hyperpolarization and relaxation of ASM. Together these results support the view that, in ASM, the EETs act through an epithelium-derived hyperpolarizing factorlike effect.
引用
收藏
页码:L965 / L973
页数:9
相关论文
共 44 条
[1]   PKG-I-ALPHA PHOSPHORYLATES THE ALPHA-SUBUNIT AND UP-REGULATES RECONSTITUTED GK(CA) CHANNELS FROM TRACHEAL SMOOTH-MUSCLE [J].
ALIOUA, A ;
HUGGINS, JP ;
ROUSSEAU, E .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (06) :L1057-L1063
[2]   Epoxyeicosatrienoic acids activate a high-conductance, Ca2+-dependent K+ channel on pig coronary artery endothelial cells [J].
Baron, A ;
Frieden, M ;
Beny, JL .
JOURNAL OF PHYSIOLOGY-LONDON, 1997, 504 (03) :537-543
[3]   DISPLAY OF THE CHARACTERISTICS OF ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR BY A CYTOCHROME P450-DERIVED ARACHIDONIC-ACID METABOLITE IN THE CORONARY MICROCIRCULATION [J].
BAUERSACHS, J ;
HECKER, M ;
BUSSE, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) :1548-1553
[4]   EPITHELIAL FACTORS - MODULATION OF THE AIRWAY SMOOTH-MUSCLE TONE [J].
BERTRAND, C ;
TSCHIRHART, E .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1993, 7 (06) :261-273
[5]   CARBAMYLCHOLINE-INDUCED AND 5-HYDROXYTRYPTAMINE-INDUCED CONTRACTION IN RAT ISOLATED AIRWAYS - INHIBITION BY CALCITONIN GENE-RELATED PEPTIDE [J].
CADIEUX, A ;
LANOUE, C ;
SIROIS, P ;
BARABE, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (01) :193-199
[6]   Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone [J].
Campbell, WB ;
Harder, DR .
CIRCULATION RESEARCH, 1999, 84 (04) :484-488
[7]   Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors [J].
Campbell, WB ;
Gebremedhin, D ;
Pratt, PF ;
Harder, DR .
CIRCULATION RESEARCH, 1996, 78 (03) :415-423
[8]  
CAPDEVILA JH, 1990, J BIOL CHEM, V265, P10865
[9]   CYTOCHROME-P450 AND THE ARACHIDONATE CASCADE [J].
CAPDEVILA, JH ;
FALCK, JR ;
ESTABROOK, RW .
FASEB JOURNAL, 1992, 6 (02) :731-736
[10]   Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids [J].
Chen, JY ;
Capdevila, JH ;
Zeldin, DC ;
Rosenberg, RL .
MOLECULAR PHARMACOLOGY, 1999, 55 (02) :288-295